Related references
Note: Only part of the references are listed.The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA
Tenna V. Henriksen et al.
MOLECULAR ONCOLOGY (2020)
Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures
Niels Lech Pedersen et al.
CLINICA CHIMICA ACTA (2020)
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Romain Meddeb et al.
CLINICAL CHEMISTRY (2019)
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol et al.
CANCER CELL (2019)
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study
Sarah Ostrup Jensen et al.
CLINICAL EPIGENETICS (2019)
Day-to-day and within-day biological variation of cell-free DNA
Anne Tranberg Madsen et al.
EBIOMEDICINE (2019)
Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
Nicholas L. Jackson Chornenki et al.
INTENSIVE CARE MEDICINE EXPERIMENTAL (2019)
Quantifying circulating cell-free DNA in humans
Romain Meddeb et al.
SCIENTIFIC REPORTS (2019)
Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Bhargavi Duvvuri et al.
FRONTIERS IN IMMUNOLOGY (2019)
Correlations of Circulating Cell-Free DNA With Clinical Manifestations in Acute Myocardial Infarction
Jin Xie et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Plasma cell-free DNA and qSOFA score predict 7-day mortality in 481 emergency department bacteraemia patients
J. Rannikko et al.
JOURNAL OF INTERNAL MEDICINE (2018)
The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
Na He et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
Joshua Moss et al.
NATURE COMMUNICATIONS (2018)
Cell-free DNA release under psychosocial and physical stress conditions
E. M. Hummel et al.
TRANSLATIONAL PSYCHIATRY (2018)
Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients
Kinga Toth et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients
Chiara Bedin et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Karen-Lise G. Spindler et al.
ONCOLOGIST (2017)
Circulating extracellular DNA levels are acutely elevated in ischaemic stroke and associated with innate immune system activation
Grant C. O'Connell et al.
BRAIN INJURY (2017)
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Scholer et al.
CLINICAL CANCER RESEARCH (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review
Mikail Gogenur et al.
CRITICAL CARE (2017)
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Thomas Reinert et al.
GUT (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
Shiva Basnet et al.
JOURNAL OF CANCER (2016)
Danish Colorectal Cancer Group Database
Peter Ingeholm et al.
CLINICAL EPIDEMIOLOGY (2016)
Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study
Mai-Britt W. Orntoft et al.
BMC CANCER (2015)
Controls to validate plasma samples for cell free DNA quantification
Niels Pallisgaard et al.
CLINICA CHIMICA ACTA (2015)
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Ellen Heitzer et al.
CLINICAL CHEMISTRY (2015)
Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey
Juulia Jylhava et al.
ATHEROSCLEROSIS (2014)
Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
T. B. Hao et al.
BRITISH JOURNAL OF CANCER (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty
Juulia Jylhava et al.
AGING CELL (2013)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments
Jim F. Huggett et al.
CLINICAL CHEMISTRY (2013)
Short-Term Treadmill Running as a Model for Studying Cell-Free DNA Kinetics In Vivo
Thomas Beiter et al.
CLINICAL CHEMISTRY (2011)
Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer
Claus Lindbjerg Andersen et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: The Vitality 90+ study
Juulia Jylhava et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2011)
The Danish National Patient Register
Elsebeth Lynge et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study
DB Panagiotakos et al.
ATHEROSCLEROSIS (2005)
Share Paper
